Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

Core Viewpoint - Xiaoming Co., Ltd. (300967) reported significant year-on-year growth in chicken product sales volume and revenue, attributed to an increase in market share despite a decline in month-on-month performance [1] Group 1: Sales Performance - In May 2025, the company sold 23.2475 million chickens, generating sales revenue of 101 million yuan, reflecting a month-on-month decrease of 6.56% in sales volume and 8.40% in revenue, but a year-on-year increase of 45.59% in sales volume and 91.17% in revenue [1] Group 2: Market Conditions - The low price of eggs in May led to losses in the egg-laying chicken farming sector, resulting in decreased replenishment enthusiasm among farming enterprises [1] - Adverse weather conditions, including high temperatures in northern regions and heavy rainfall in southern markets, raised concerns about egg quality, leading to a lack of confidence in future market conditions [1] - The market focus shifted towards inventory clearance, with limited demand boost from the Dragon Boat Festival holiday [1] Group 3: Cost Factors - Feed costs remained relatively stable, failing to provide effective cost support for egg prices [1]

证券代码：300967 证券简称：晓鸣股份 公告编号：2025-100 宁夏晓鸣农牧股份有限公司 2025 年 5 月鸡产品销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2025 年 5 月鸡产品销售情况 宁夏晓鸣农牧股份有限公司（以下简称"公司"）2025 年 5 月销售鸡产品 2,324.75 万羽，销售收入 10,085.81 万元，环比变动分别为-6.56%、-8.40%，同 比变动分别为 45.59%、91.17%。 二、原因说明 2025 年 5 月，公司鸡产品销售数量、销售收入同比有较大幅度增长，主要 系公司市占率的进一步提升使得量价同比提高。 | | 月份 | | 销售数量（万羽） | | 销售收入（万元） | 价（元/羽） | | 鸡产品销售均 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 当月 | 当月 | 当年累计 | | 当年累计 | 当月 | | 2025 | 年 | 1 月 | 2,633.58 | 10,702.14 | 2, ...

| 股票代码：300967 | 股票简称：晓鸣股份 | | --- | --- | | 债券代码：123189 | 债券简称：晓鸣转债 | 宁夏晓鸣农牧股份有限公司 向不特定对象发行可转换公司债券 第五次临时受托管理事务报告 （2025 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"） 《宁夏晓鸣农牧股份有限公司与华西证券股份有限公司关于 2022 年创业板向不 特定对象发行可转换公司债券之债券受托管理协议》（以下简称"《受托管理协 议》"）《宁夏晓鸣农牧股份有限公司创业板向不特定对象发行可转换公司债券 募集说明书》（以下简称"《募集说明书》"）等相关公开信息披露文件、第三 方中介机构出具的专业意见等，由本期债券受托管理人华西证券股份有限公司 （以下简称"华西证券"）编制。华西证券对本报告中所包含的从上述文件中引 述内容和信息未进行独立验证，也不就该等引述内容和信息的真实性、准确性和 完整性做出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为华 ...

Core Viewpoint - Ningxia Securities Regulatory Bureau is implementing measures to support private enterprises and enhance high-quality development through comprehensive company visits and problem-solving initiatives [1][2][3][4] Group 1: Company Visits and Support - The bureau aims for full coverage of listed companies in the region, having conducted five joint visits this year, with plans for a second round by the end of the year [2] - The bureau is focusing on high-tech, manufacturing, and traditional manufacturing companies, interpreting policies related to mergers, acquisitions, and dividends [2] - Companies eligible for dividends have announced a total cash dividend of 3.689 billion, a year-on-year increase of 41.85%, with the number of dividend-paying companies reaching a historical high [2] Group 2: Risk Management and Governance - The bureau emphasizes proactive risk management by visiting companies to assess their operational conditions and governance structures [3] - Two companies are set to raise over 3.4 billion through targeted placements and public REITs, with the bureau engaging in detailed discussions about their management and industry conditions [3] - The bureau is focusing on high-risk companies to ensure they implement necessary improvements and manage expectations effectively [3] Group 3: Addressing Challenges for SMEs - The bureau is addressing urgent issues faced by small and medium-sized enterprises, coordinating solutions for nearly 70% of the problems identified [4] - Specific companies in niche markets are being supported to enhance their core businesses and develop new productive capacities [4] - A mechanism for ongoing visits and follow-ups is being established to ensure continuous support and problem resolution for listed companies [4]

股票代码：300967 股票简称：晓鸣股份 债券代码：123189 债券简称：晓鸣转债 宁夏晓鸣农牧股份有限公司 向不特定对象发行可转换公司债券 第四次临时受托管理事务报告 （2025 年度） 债券受托管理人 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"） 《宁夏晓鸣农牧股份有限公司与华西证券股份有限公司关于 2022 年创业板向不 特定对象发行可转换公司债券之债券受托管理协议》（以下简称"《受托管理协 议》"）《宁夏晓鸣农牧股份有限公司创业板向不特定对象发行可转换公司债券 募集说明书》（以下简称"《募集说明书》"）等相关公开信息披露文件、第三 方中介机构出具的专业意见等，由本期债券受托管理人华西证券股份有限公司 （以下简称"华西证券"）编制。华西证券对本报告中所包含的从上述文件中引 述内容和信息未进行独立验证，也不就该等引述内容和信息的真实性、准确性和 完整性做出任何保证或承担任何责任。 二〇二五年六月 重要声明 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为华西证券所作的承诺 或声明。在任何情况下，投资者依据本 ...

| 股票代码：300967 | 股票简称：晓鸣股份 | | --- | --- | | 债券代码：123189 | 债券简称：晓鸣转债 | 宁夏晓鸣农牧股份有限公司 向不特定对象发行可转换公司债券 第四次临时受托管理事务报告 （2025 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"） 《宁夏晓鸣农牧股份有限公司与华西证券股份有限公司关于 2022 年创业板向不 特定对象发行可转换公司债券之债券受托管理协议》（以下简称"《受托管理协 议》"）《宁夏晓鸣农牧股份有限公司创业板向不特定对象发行可转换公司债券 募集说明书》（以下简称"《募集说明书》"）等相关公开信息披露文件、第三 方中介机构出具的专业意见等，由本期债券受托管理人华西证券股份有限公司 （以下简称"华西证券"）编制。华西证券对本报告中所包含的从上述文件中引 述内容和信息未进行独立验证，也不就该等引述内容和信息的真实性、准确性和 完整性做出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为华 ...

Mergers and Acquisitions - Bohai Automotive plans to acquire 51% equity stakes in Beijing Beiqi Moulding Technology Co., Ltd. and other companies through a combination of issuing shares and cash payment, indicating a significant asset restructuring [1] - Zhejiang Longsheng intends to purchase 37.57% of the shares in Desida Global Holdings for a total consideration of $697 million [2] - Hangzhou High-tech's subsidiary aims to acquire assets worth 19.29 million yuan, including machinery and electronic equipment, to support its business development [3] Shareholding Changes - Wuhan Tianyuan's major shareholder, Konka Group, plans to reduce its holdings by up to 19.90 million shares, representing 3% of the total share capital [4] - Xiaoming Co. announces that its shareholder, Xiamen Chentu, along with its concerted parties, intends to reduce their holdings by up to 5.57 million shares, accounting for 2.97% of the total share capital [5] - Dianzhi Technology's board member and supervisor plan to sell a small number of shares for personal financial needs, with reductions of 5,000 shares and 40,000 shares respectively [6] Risk Matters - ST Tianyu is under investigation by the police for alleged fund misappropriation involving its actual controller, which may impact investor confidence [7] - ST Jinglan has been subjected to an investigation by the China Securities Regulatory Commission for suspected information disclosure violations, although it claims this will not significantly affect its operations [9] - ST Yazhen warns of potential stock trading anomalies due to a significant price increase of 93.14% over a short period, indicating possible irrational market behavior [10]

证券代码：300967 证券简称：晓鸣股份 公告编号：2025-085 宁夏晓鸣农牧股份有限公司 一、股东的基本情况 1.减持股东：厦门辰途、辰途第一产业基金、谢诺投资为一致行动人关联关 系，受同一实际控制人控制。 2.股东持有公司股份情况 关于合计持股 5%以上股东减持股份的预披露公告 股东广州谢诺辰途股权投资管理有限公司——厦门辰途创业投资合伙企业 （有限合伙）及其一致行动人广州谢诺辰途股权投资管理有限公司——辰途第一 产业股权投资基金、广州谢诺投资集团有限公司保证向本公司提供的信息内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 宁夏晓鸣农牧股份有限公司（以下简称"公司"或"本公司"）的股东广州 谢诺辰途股权投资管理有限公司——厦门辰途创业投资合伙企业（有限合伙）（以 下简称"厦门辰途"，持本公司 8,194,295 股，占本公司总股本比例 4.37%）及 其一致行动人广州谢诺辰途股权投资管理有限公司——辰途第一产业股权投资 基金（以下简称"辰途第一产业基金"，持本公司 2,476,814 股，占本公司总股 本比 ...

另外，截至目前，宁夏已有11家次上市公司开展回购增持超5亿元，其中3家公司积极使用了股票回购增 持再贷款工具，占比18.75%。 北方民族大学经济学院教授张晓凤在接受《证券日报》记者采访时表示，宁夏上市公司业绩实现稳健增 长，并积极通过现金分红、回购增持等多种方式回馈投资者，非常有助于提升投资者的获得感，并提振 投资者的投资信心。 为进一步加强宁夏辖区上市公司与投资者的沟通交流，切实保护投资者合法权益，5月28日，在宁夏证 监局指导下，由宁夏上市公司协会、深圳市全景网络有限公司主办的"宁夏辖区上市公司投资者集体接 待日暨2024年度业绩说明会"在银川市举行。截至目前，宁夏已连续18年举办投资者集体接待日暨业绩 说明会活动。 2024年，宁夏16家上市公司实现营业收入623.38亿元，同比增长4.40%；实现净利润64.77亿元，同比增 长5.43%。同时，宁夏9家上市公司披露实施现金分红36.89亿元，同比增长41.85%，分红上市公司家数 与分红金额均创历史新高，显示出宁夏上市公司以扎实业绩和真金白银回报投资者的力度进一步增强。 宁夏证监局上述相关负责人表示，宁夏证监局将始终把保护投资者合法权益作为工作的出 ...